Genetic Technologies strategic restructure delivers cost savings
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) today released a business update covering the company’s activities during the September...…
0,029€
-40,82%
Echtzeit-Aktienkurs GENETIC TEC.
Bid:
Ask:
Nachrichten zur GENETIC TEC. Aktie
Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a…
Genetic Technologies secures partnership with CancerIQ to expand cancer prevention programs
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has secured a partnership agreement with Chicago-based healthcare technology company CancerIQ...…
Genetic Technologies launches geneType™ on its EasyDNA platform
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has launched its geneType™ Risk Assessment portfolio on its wholly-owned EasyDNA platform,...…
Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15
MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”),…
Genetic Technologies Strategic Restructure Driving USA Sales Growth
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a…
Genetic Technologies focuses on core business and revenue growth
Following a comprehensive operations review, Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has implemented a strategic restructure which...…
Genetic Technologies to expand to Canadian and New Zealand markets
…
Genetic Technologies delivers update on geneType and its multi-brand global strategy
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has released a new investor presentation providing a business update on the company and its...…
Genetic Technologies’ geneType finds 79.5% of people tested at risk of serious disease
Results from commercial sales of predictive testing across the US and Australia have revealed the power of the geneType multi-risk test of Genetic...…
Genetic Technologies expands North American operational capacity with launch of tests at leading genetic laboratory
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has begun testing operations in the United States, offering genomics-based tests in health,...…
Genetic Technologies in distribution agreement with Stayhealthy for Multi-Risk Test
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF), a leader in genomics-based tests in health, wellness and serious disease, has signed a...…
Genetic Technologies unveils major cancer risk Test at California event
…
Genetic Technologies launches novel risk assessment test covering 100% risk of breast and ovarian cancer
Genomics-based biotech Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has released its novel Comprehensive Risk Assessment test, which...…
Genetic Technologies unlocks access to huge network with Wellworks sales and marketing agreement
Genomics-based leader in health, wellness and serious disease Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has struck up a strategic joint...…
Genetic Technologies raises US$2 million as it eyes global expansion
…
Genetic Technologies closes US$2 million Registered Direct Offering
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF), a leader in guideline-driven genomics-based tests in health, wellness and serious diseases,...…
Genetic Technologies launches US$2 million share offering to fund expansion and innovation
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) is targeting gross proceeds of around US$2 million from a share offering announced today,...…
Genetic Technologies Announces $2 Million Registered Direct Offering
Genetic Technologies Announces $2 Million Registered Direct Offering…
Genetic Technologies has portfolio of new diagnostic tests for GeneType precision oncology
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has established a precision oncology division that will encompass a highly anticipated...…
Genetic Technologies to pilot geneType test in US breast screen centres
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) will establish a clinical implementation study using geneType in breast imaging centres...…
Genetic Technologies unveils pioneering genomic-based comprehensive risk assessment test
Genomics-based testing company Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has made a breakthrough in risk assessment testing for serious...…
Genetic Technologies launching US customer digital media sales campaign
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) is launching a wide-reaching customer-targeted digital advertising campaign in the United...…